Skip to main content
MapleLMS Implementation
Conferences and Meetings 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II

905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II

Short name: 905. Outcomes Research: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster II
Course start date: 11/05/2025

Sections

General
0 activities

"There Is so Much Power in Just Believing Someone": Understanding the Lived Experiences of Women with Heavy Vaginal Blood Loss
Clinical Characteristics and Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Study from a Tertiary Care Centre in South India
Clinical Monitoring Practices Among Adult Patients with Pyruvate Kinase Deficiency Who Have Never Been Transfused
Comparing Extended Vs. Standard Postoperative Thromboprophylaxis in Patients Undergoing Abdominopelvic Surgery for Malignancy; A Population-Based Cohort Study
Impact of Obesity on Anticoagulation Dosing and Clinical Outcomes in Pediatric Patients with Venous Thrombo-Embolism
Inhibitors Significantly Impair Quality of Life for Hemophilia a Patients
Investigation of the Impact of Medication on the Mental Health of Hemophiliacs
Measuring the Utility of the Adolescent Menstrual Bleeding Questionnaire (aMBQ) in a Culturally Diverse Adolescent Population
Patient Reported Outcomes in Vexas Syndrome
Real-World Adherence and Persistence to Emicizumab Using a National US Claims Database
Real-World Treatment Patterns and Outcomes in Patients with Primary Immune Thrombocytopenia Treated with Avatrombopag in the United States: Real-AVA 2.0 Interim Analysis Results
Sentiment Analysis Applied to Digital Conversations Among Warm Autoimmune Hemolytic Anemia (wAIHA) Patients Receiving Rituximab and/or Blood Transfusion
The Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Patient Registry: Highlights of the Data from the First Three Years
Title: Real-World Utilization of Human Fibrinogen Concentrate in Managing Bleeding in Adult and Pediatric Patients: A Retrospective Study
Usage of Disease-Specific Patient Reported Outcome Measures (PROMs) for Assessing Quality of Life (QoL) in Industry Sponsored Hemophilia Interventional Trials